The Gastrointestinal Drugs Advisory Committee of the FDA has recommended the approval of XIFAXAN® (rifaximin) tablets (550 mg) for the maintenance of remission of hepatic encephalopathy.24 February, 2010

Researchers have discovered a protein crucial in mediating the anti-inflammatory actions of nuclear lipid receptors. The findings create new possibilities for treating metabolic diseases associated with inflammation, such as diabetes.19 February, 2010

Silence Therapeutics announced recently that the United States Patent and Trademark Office has issued them a notice of allowance on a patent application covering a novel cancer target.10 February, 2010

UK cancer patients to gain access to the latest robotic radiosurgery treatments with the announcement that the Clatterbridge Centre for Oncology has ordered the country’s first Novalis Tx™ radiosurgery platform.09 February, 2010

A drug safety warning from the MHRA on the dangers of switching immunosuppressants calls into question the safety of the Department of Health’s proposal for Automatic Generic Substitution.01 February, 2010

Members' Login

Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how customers
use our website.Our site won't work without them. By continuing to use our website you accept our use of cookies.
Find out more about cookies×